Boston Trust Walden
CME icon

Boston Trust Walden’s CME Group CME Stock Holding History

Boston Trust Walden’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.16M Buy
31,142
+13,791
+79% +$3.64M 0.07% 211
2026
Q2 		$3.83M Buy
17,351
+2,200
+15% +$609K 0.03% 238
2026
Q1 		$4.47M Buy
15,151
+702
+5% +$209K 0.04% 238
2025
Q4 		$3.95M Sell
14,449
-665
-4% -$181K 0.03% 232
2025
Q3 		$4.08M Sell
15,114
-1,045
-6% -$284K 0.03% 232
2025
Q2 		$4.45M Sell
16,159
-560
-3% -$152K 0.03% 226
2025
Q1 		$4.44M Buy
16,719
+150
+0.9% +$37K 0.03% 226
2024
Q4 		$3.85M Buy
16,569
+935
+6% +$215K 0.03% 232
2024
Q3 		$3.45M Buy
15,634
+14,604
+1,418% +$3.02M 0.02% 236
2024
Q2 		$202K Buy
1,030
+100
+11% +$20.7K ﹤0.01% 375
2024
Q1 		$200K Buy
+930
New +$195K ﹤0.01% 370
2023
Q4 		– Sell
-1,148
Closed -$230K – 376
2023
Q3 		$230K Sell
1,148
-2,602
-69% -$517K ﹤0.01% 351
2023
Q2 		$695K Buy
3,750
+50
+1% +$9.24K 0.01% 295
2023
Q1 		$709K Buy
+3,700
New +$669K 0.01% 293

Other funds holding CME

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
PineStone Asset Management
PineStone Asset Management Montreal, Quebec, Canada $15.4B AUM 14.92% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
M&G plc
M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return

Boston Trust Walden's CME Position: Q3 2026 in Review

Boston Trust Walden increased its CME Group (CME) stake by 79% in Q3 2026, buying an estimated $3.64M and bringing the position to 31,142 shares worth $8.16M. The position accounts for 0.07% of the portfolio, ranked #211.

Boston Trust Walden first reported a position in CME in Q1 2023 and has held it in 14 quarters since. 1,015 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Boston Trust Walden held 31,142 shares of CME Group worth $8.16M as of Q3 2026.
  • Boston Trust Walden bought 13,791 CME Group shares in Q3 2026, an estimated $3.64M.
  • CME Group made up 0.07% of Boston Trust Walden's portfolio in Q3 2026, its #211 holding.
  • Boston Trust Walden first reported a position in CME Group in Q1 2023 and has held it in 14 quarters since.
  • 1,015 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Boston Trust Walden's 13F filing for Q3 2026, filed 30 Oct 2026.